Boehringer Ingelheim convenes “Detect the SOS” Collective for public health mission

RIDGEFIELD, Conn., January 28, 2026 – Today, Boehringer Ingelheim and the Detect the SOS Collective, a group of professional organizations, advocates, patients and caregivers, launched a new public health mission: elevate awareness of urine albumin-to-creatinine ratio (uACR) screening to help uncover hidden risks for chronic kidney disease (CKD) and related cardiovascular (CV) events like heart attack or stroke. Read more...